Using short‐term response information to facilitate adaptive randomization for survival clinical trials
Xuelin Huang(The University of Texas MD Anderson Cancer Center), Donald A. Berry(Berry & Associates (United States)), Jing Ning(The University of Texas MD Anderson Cancer Center), Elihu H. Estey(University of Washington), Jean‐Pierre J. Issa(Coriell Institute For Medical Research), Yisheng Li(The University of Texas MD Anderson Cancer Center)
Cited by 60
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k